Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kornelia Chmurzyńska
Observed names:
K. Chmurzyńska,
Kornelia Chmurzynska
Institution:
National Institute of Geriatrics, Rheumatology and Rehabilitation
Observed institution:
National Institute of Geriatrics, Rheumatology and Rehabilitation
ORCID:
0000-0002-8301-105X
Observed ORCID:
0000-0002-8301-105X
OpenAlex ID:
A5078138804
Observational study of inflammatory arthritis treatment by etanercept originator switched to an etanercept biosimilar
2019
·
Anna Felis-Giemza
, Kornelia Chmurzyńska
, et al.
·
Reumatologia/Rheumatology
·
15
PDF
Revising diagnosis of juvenile idiopathic arthritis in adults: a single-center retrospective study
2023
·
Anna Felis-Giemza
, Kornelia Chmurzyńska
, et al.
·
Rheumatology International
·
9
PDF
Multicenter evaluation of tofacitinib retention and safety in rheumatoid arthritis – why cardiovascular risk factors do not equate to overt risk
2024
·
Anna Felis-Giemza
, Mateusz Moskal
, et al.
·
Reumatologia/Rheumatology
·
4
PDF
Thrombotic Markers in Plasma as Predictors of Response in Rheumatoid Arthritis Patients Treated with Baricitinib – Pilot Observation
2025
·
Anna Felis-Giemza
, Kornelia Chmurzynska
, et al.
·
Archivum Immunologiae et Therapiae Experimentalis
·
1
PO:04:106 Rituximab for active rhupus syndrome with severe thrombocytopenia after multiple DMARD failures: a case report
2026
·
Iryna Naishtetik
, Jacek Falkowski
, et al.
·
Lupus Science & Medicine
PDF
Ab0225 Increased Homocysteine Levels During the First 3 Months of Baricitinib Therapy in Patients With Rheumatoid Arthritis
2024
·
A. Felis-Giemza
, K. Chmurzyńska
, et al.
·
Annals of the Rheumatic Diseases
Show more works
View as search
Works count:
6
Citation count:
29
H-index:
3
I10-index:
1
Year
Topic
Type